NDAA yields 2.71% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 8
Combined, NDAA + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NDAA + JNJ for your $10,000?
NDAA aims to maximize return opportunities by adapting investments to market shifts through a proprietary, data-driven, 360-degree approach. This serves as a broad asset allocation guide for a selection of passively managed ETFs, integrating data from four key pillars: macroeconomic, fundamental, technical, and sentiment analyses. The strategy allows for a holistic view of market conditions and dynamically shifts assets across equities, fixed income, commodities, and money markets. The raw data inputs utilized are sourced from market data providers such as Bloomberg, S&P, MSCI, and others. Typically, the fund targets a 60/40 allocation to equities and bonds, with adjustments made based on prevailing market conditions. Note that the portfolio may fully switch to either equities or bonds. Holdings will generally consist of 5 to 20 underlying ETFs and may also include cash or cash equivalents. On a monthly basis, the fund reviews its holdings and may experience a high portfolio turnover rate.
Full NDAA Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.